STAT2-dependent restriction of Zika virus by human macrophages but not dendritic cells.


Journal

Emerging microbes & infections
ISSN: 2222-1751
Titre abrégé: Emerg Microbes Infect
Pays: United States
ID NLM: 101594885

Informations de publication

Date de publication:
Dec 2021
Historique:
pubmed: 13 5 2021
medline: 3 11 2021
entrez: 12 5 2021
Statut: ppublish

Résumé

Zika virus (ZIKV) is an emerging mosquito-borne flavivirus that poses significant threats to global public health. Macrophages and dendritic cells are both key sentinel cells in the host immune response and play critical roles in the pathogenesis of flavivirus infections. Recent studies showed that ZIKV could productively infect monocyte-derived dendritic cells (moDCs), but the role of macrophages in ZIKV infection remains incompletely understood. In this study, we first compared ZIKV infection in monocyte-derived macrophages (MDMs) and moDCs derived from the same donors. We demonstrated that while both MDMs and moDCs were susceptible to epidemic (Puerto Rico) and pre-epidemic (Uganda) strains of ZIKV, virus replication was largely restricted in MDMs but not in moDCs. ZIKV induced significant apoptosis in moDCs but not MDMs. The restricted virus replication in MDMs was not due to inefficient virus entry but was related to post-entry events in the viral replication cycle. In stark contrast with moDCs, ZIKV failed to inhibit STAT1 and STAT2 phosphorylation in MDMs. This resulted in the lack of efficient antagonism of the host type I interferon-mediated antiviral responses. Importantly, depletion of STAT2 but not STAT1 in MDMs significantly rescued the replication of ZIKV and the prototype flavivirus yellow fever virus. Overall, our findings revealed a differential interplay between macrophages and dendritic cells with ZIKV. While dendritic cells may be exploited by ZIKV to facilitate virus replication, macrophages restricted ZIKV infection.

Identifiants

pubmed: 33979266
doi: 10.1080/22221751.2021.1929503
pmc: PMC8205058
doi:

Substances chimiques

Interferon Type I 0
STAT1 Transcription Factor 0
STAT1 protein, human 0
STAT2 Transcription Factor 0
STAT2 protein, human 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1024-1037

Références

Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):2024-2029
pubmed: 28167751
J Infect Dis. 2014 May 1;209(9):1331-42
pubmed: 24065148
J Infect. 2016 May;72(5):507-24
pubmed: 26940504
PLoS Pathog. 2014 Dec 04;10(12):e1004541
pubmed: 25474197
Trends Immunol. 2015 Mar;36(3):124-38
pubmed: 25704559
Antiviral Res. 2018 Dec;160:38-47
pubmed: 30326204
PLoS Pathog. 2013 Mar;9(3):e1003265
pubmed: 23555265
ACS Infect Dis. 2020 Jul 10;6(7):1745-1758
pubmed: 32329611
Int J Infect Dis. 2020 Jul;96:579-581
pubmed: 32497802
EMBO Rep. 2016 Dec;17(12):1766-1775
pubmed: 27797853
Eur J Immunol. 2018 Jul;48(7):1120-1136
pubmed: 29572905
Sci Rep. 2018 Apr 3;8(1):5440
pubmed: 29615676
Nat Commun. 2018 Jan 29;9(1):414
pubmed: 29379028
J Infect Dis. 2020 Aug 4;222(5):734-745
pubmed: 32563187
Cell Host Microbe. 2016 Jun 8;19(6):882-90
pubmed: 27212660
Clin Microbiol Rev. 2012 Oct;25(4):635-48
pubmed: 23034323
Nat Commun. 2021 Jan 8;12(1):134
pubmed: 33420022
N Engl J Med. 2009 Jun 11;360(24):2536-43
pubmed: 19516034
Cell Host Microbe. 2012 Sep 13;12(3):360-72
pubmed: 22980332
J Immunol. 2006 Feb 1;176(3):1741-9
pubmed: 16424204
JCI Insight. 2016 Aug 18;1(13):
pubmed: 27595140
mBio. 2019 Jul 16;10(4):
pubmed: 31311882
J Infect Dis. 2007 Jun 15;195(12):1808-17
pubmed: 17492597
J Virol. 2002 Jul;76(13):6435-41
pubmed: 12050355
Trop Med Int Health. 2017 May;22(5):594-603
pubmed: 28214373
J Virol. 2018 Jun 29;92(14):
pubmed: 29743368
J Leukoc Biol. 2002 Mar;71(3):445-57
pubmed: 11867682
J Virol. 2014 Jul;88(13):7276-85
pubmed: 24741106
J Exp Med. 2006 Feb 20;203(2):413-24
pubmed: 16461338
Immunity. 2006 Sep;25(3):361-72
pubmed: 16979568
Int J Mol Sci. 2019 Jan 17;20(2):
pubmed: 30658479
Cell Host Microbe. 2016 Jul 13;20(1):83-90
pubmed: 27247001
J Virol. 2015 Sep;89(17):8880-96
pubmed: 26085147
J Biol Chem. 2018 Jul 27;293(30):11709-11726
pubmed: 29887526
J Gen Virol. 2016 Jul;97(7):1531-1536
pubmed: 27046075
Cell Host Microbe. 2014 Sep 10;16(3):314-327
pubmed: 25211074
J Immunol. 2008 Nov 1;181(9):5865-74
pubmed: 18941175
Nat Rev Immunol. 2011 Oct 14;11(11):723-37
pubmed: 21997792
PLoS Pathog. 2012 Jan;8(1):e1002465
pubmed: 22241991
J Virol. 2001 Apr;75(8):3501-8
pubmed: 11264339
PLoS Pathog. 2011 Feb;7(2):e1001297
pubmed: 21379341
PLoS Pathog. 2017 Feb 2;13(2):e1006164
pubmed: 28152048
Antiviral Res. 2017 May;141:29-37
pubmed: 28185815
Eur J Immunol. 2009 Oct;39(10):2809-21
pubmed: 19637226
J Virol. 2011 Oct;85(19):10058-68
pubmed: 21752905
J Virol. 2006 Oct;80(19):9349-60
pubmed: 16973541
J Infect Dis. 2016 Mar 15;213(6):904-14
pubmed: 26203058
Virology. 2014 Apr;454-455:197-205
pubmed: 24725946
Cell Rep. 2017 Jan 10;18(2):324-333
pubmed: 28076778
Clin Infect Dis. 2020 Sep 12;71(6):1400-1409
pubmed: 32270184
Immunobiology. 2010 Nov;215(11):884-93
pubmed: 20153075
J Immunol. 2009 Aug 15;183(4):2462-74
pubmed: 19635909
Front Immunol. 2014 Oct 17;5:514
pubmed: 25368618
Cell Rep. 2017 Oct 10;21(2):517-532
pubmed: 29020636
Trends Parasitol. 2017 Aug;33(8):645-657
pubmed: 28495485
Lancet Microbe. 2020 May;1(1):e14-e23
pubmed: 32835326
J Biol Chem. 1999 Sep 3;274(36):25343-9
pubmed: 10464260
Antiviral Res. 2017 Sep;145:33-43
pubmed: 28712942

Auteurs

Dong Yang (D)

State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Pokfulam, People's Republic of China.

Hin Chu (H)

State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Pokfulam, People's Republic of China.

Gang Lu (G)

Key Laboratory of Tropical Translational Medicine of Ministry of Education, Hainan Medical University, Haikou, People's Republic of China.
Hainan-Medical University-The University of Hong Kong Joint Laboratory of Tropical Infectious Diseases, Hainan Medical University, Haikou, Hainan, People's Republic of China, and the The University of Hong Kong, Pokfulam, People's Republic of China.
Department of Pathogen Biology, Hainan Medical University, Haikou, Hainan, People's Republic of China.

Huiping Shuai (H)

State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Pokfulam, People's Republic of China.

Yixin Wang (Y)

State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Pokfulam, People's Republic of China.

Yuxin Hou (Y)

State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Pokfulam, People's Republic of China.

Xi Zhang (X)

State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Pokfulam, People's Republic of China.

Xiner Huang (X)

State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Pokfulam, People's Republic of China.

Bingjie Hu (B)

State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Pokfulam, People's Republic of China.

Yue Chai (Y)

State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Pokfulam, People's Republic of China.

Terrence Tsz-Tai Yuen (TT)

State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Pokfulam, People's Republic of China.

Xiaoyu Zhao (X)

State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Pokfulam, People's Republic of China.

Andrew Chak-Yiu Lee (AC)

State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Pokfulam, People's Republic of China.

Ziwei Ye (Z)

State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Pokfulam, People's Republic of China.

Cun Li (C)

State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Pokfulam, People's Republic of China.

Kenn Ka-Heng Chik (KK)

State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Pokfulam, People's Republic of China.

Anna Jinxia Zhang (AJ)

State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Pokfulam, People's Republic of China.

Jie Zhou (J)

State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Pokfulam, People's Republic of China.

Shuofeng Yuan (S)

State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Pokfulam, People's Republic of China.

Jasper Fuk-Woo Chan (JF)

State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Pokfulam, People's Republic of China.
Hainan-Medical University-The University of Hong Kong Joint Laboratory of Tropical Infectious Diseases, Hainan Medical University, Haikou, Hainan, People's Republic of China, and the The University of Hong Kong, Pokfulam, People's Republic of China.
Carol Yu Centre for Infection, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, People's Republic of China.
Department of Microbiology, Queen Mary Hospital, Pokfulam, People's Republic of China.
Department of Clinical Microbiology and Infection Control, The University of Hong Kong-Shenzhen Hospital, Shenzhen, People's Republic of China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH